Company Quick10K Filing
CNL Healthcare Properties
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-11-01 Officers
8-K 2019-08-27 Regulation FD, Other Events, Exhibits
8-K 2019-05-21 Regulation FD, Other Events, Exhibits
8-K 2019-05-15 Enter Agreement, M&A, Off-BS Arrangement, Regulation FD, Exhibits
8-K 2019-03-21 Regulation FD, Exhibits
8-K 2019-03-13 Regulation FD, Other Events, Exhibits
8-K 2019-01-24 Regulation FD, Other Events, Exhibits
8-K 2019-01-24 Regulation FD, Other Events, Exhibits
8-K 2018-12-27 Enter Agreement, Regulation FD, Exhibits
8-K 2018-12-18 Shareholder Vote
8-K 2018-06-22 Other Events, Exhibits
8-K 2018-04-03 Leave Agreement
8-K 2018-02-27 Officers
8-K 2018-02-14 Regulation FD, Exhibits
8-K 2018-02-07 Regulation FD, Other Events, Exhibits
8-K 2018-01-30 Officers
8-K 2018-01-23 Regulation FD, Other Events, Exhibits

CNL Healthcare Properties Financials

-

CHP Metrics, Comps, Filings


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Quarter)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Apollo Education (APOL) 1,063 1,955 886 2,000 0 -20 98 579
China Crawfish (CACA) 0 0 0 0 -0 -0 -0
Mirenco (MREO)
Weyland Tech (WEYL) 11 5 29 -1 -4 -4 -5
Lingo Media (LMDC) 1 1 0 0 0 0 -0
Granite Real Estate (GRP)
Wewin Group (WWIN) 0 0 0 0 -0 -0 -0
MWF Global (MWF) 0 0 -0 -0 -0
Frontier Digital Media Group (FDMG) 0 0 0 0 -0 -0 -0
Brighthouse Life Insurance Co of Ny (BHNY) 9,066 8,030 237 0 0 3 -190
G-Mes Holdings (GMES) 1 1 1 1 0 0 -0
Baynon (BNON) 0 0 0 0 -0 -0 0
Immune Therapeutics (IMUN) 0 0 13 0 0 -5 -5 -0
Green Planet Bio Engineering (GPLB) 3 0 0 0 0 -0 -0 3
Blue Sphere (BLSP) 1 44 87 8 3 -14 -14 9
Therapeutic Solutions (TSOI) 0 0 2 0 0 -2 -1 0
Stem Holdings (STEMH) 41 6 1 0 -8 -7 -5
SpringWorks (SWTX)
Clean Coal Technologies (CCTC) 0 17 0 0 -6 -3 1
Ryanair Holdings (RYAA) 13,251 8,036 0 0 0 0 -35

Balance Sheet ($MM)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash1061339181455454441658391116122516954655559616972656772656614961
Accounts Receivable
Inventory
PP&E8282852302292935058491,0191,2091,3621,6581,7131,9082,2512,4702,4622,4542,4462,4672,4922,5582,4972,4882,4652,4481,4751,4551,4431,432
Assets11961551923383394676721,0141,2011,4321,6231,9892,0782,2742,6002,8432,8082,8172,8062,8282,8232,8172,8082,7942,7742,7422,7222,7062,7751,682
Accounts Payable
Long-Term Debt
Liabilities16593981971381792935626908539251,1171,0751,1371,3391,5841,5861,6311,6481,6731,6921,7131,7371,7411,7521,7471,7541,7641,841776
Stockholders' Equity103162951412012873794525125796988711,0031,1371,2611,2571,2201,1841,1571,1531,1291,1021,0691,0511,020993966940933904
Income Statement ($MM)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue12238141521336150566567808893949695969810210310510678808080
Cost of Revenue
Gross Profit
R&D
SG&A
Tax-000-0-000000000000000-9111111
Net Income-2-3-3-5-4-2-2-9-13-12-12-15-18-13-19-17-14-12-127-7-8-110-8-7-3-710329
Cash Flow ($MM)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-20-4030-0618152611
Cash Investing-89-51-9-9-86-201-348-204-4-10771,232
Cash Financing8659395124191347194-21-5-20-1,331